We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Interleukin-8 Predicts Outcomes for Pediatric Septic Shock

By HospiMedica International staff writers
Posted on 27 Aug 2008
Measurement of an immune system protein, interleukin-8 (IL-8) within 24 hours of a child being admitted to a hospital for septic shock has been shown to predict survival.

IL-8 is secreted into the blood as part of the body's immune system response, the chief defense mechanism against infection-related conditions such as septic shock. More...
Previous research has demonstrated that higher blood levels of IL-8 are associated with more severe cases of pediatric septic shock and a greater chance of death. That work also pointed to the potential value of IL-8 as an early diagnostic marker of systemic bacterial infections.

A new study by the same team reported an IL-8 blood level at or below 220 pg/ml should allow doctors to predict with 95% accuracy which of the children with septic shock can survive through conventional antibiotics and therapies for at least 28 days following admission. In addition, measuring IL-8 levels would make it possible to screen lower risk patients out of interventional clinical trials of experimental therapies.

Because the reagents to measure IL-8 are available and blood samples can readily be obtained from patients, Dr. Wong, professor of pediatrics at the University of Cincinnati College of Medicine (OH, USA), is looking to develop a point-of-care test that can be used to detect the IL-8 biomarker in septic shock patients, especially patients being considered for clinical trials.

The study was reported in the August 1, 2008, issue of the American Journal of Respiratory and Critical Care Medicine.

Related Links:
University of Cincinnati College of Medicine



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.